Parkinson's disease

News

Ex-broadcaster Paxman hands Parkinson’s wish list to UK PM

To mark World Parkinson’s Day, former broadcaster Jeremy Paxman has delivered a list of recommendations for improving how the disease is managed in the UK to Prime Ministe

News

Trial finds benefit for GLP-1 agonist in Parkinson’s

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for t

News

Acorda filed for bankruptcy, and Merz is eyeing its assets

Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Mer

News

AbbVie’s 24-hour Parkinson’s therapy to roll out on NHS

Around 1,000 people with Parkinson’s disease will be able to access treatment with AbbVie’s Produodopa, the first therapy that can be delivered by a 24-hour subcutaneous i

News

Lundbeck study knocks confidence in alpha-syn as CNS target

A phase 2 trial of Lundbeck’s alpha-synuclein-targeting drug Lu AF82422 has failed to reach statistical significance in patients with multiple system atrophy (MSA), althou

News

Remote Parkinson’s monitoring tech backed by NICE

In its second guidance on digital health technologies within a week, NICE has endorsed five remote monitoring devices for patients with Parkinson’s disease that can be use

Ex-broadcaster Paxman hands Parkinson’s wish list to UK PM

Trial finds benefit for GLP-1 agonist in Parkinson’s

Acorda filed for bankruptcy, and Merz is eyeing its assets

AbbVie’s 24-hour Parkinson’s therapy to roll out on NHS

Lundbeck study knocks confidence in alpha-syn as CNS target

Remote Parkinson’s monitoring tech backed by NICE

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Parkinson's disease

Editor's Picks